Vir Biotechnology
Leadership moves, last update 4 weeks ago
Pharma biotech · Headquarters San Francisco, United States
Everything we hold on Vir Biotechnology, newest first. Every line links to the filing or report it came from.
- 2026-07-24Headcount Not Stated Leadership moves
Vir Biotechnologyの株価下落、CFOのO’Byrne氏が退任
Vir Biotechnology, a biotech company, announced CFO O'Byrne's departure alongside a stock decline, leaving finance leadership succession unaddressed. The report names no hiring plans for the vacated role.
- 2026-03-04Headcount Not Stated Leadership moves
Vir Biotechnology, Inc. 8-K filing (Item 5.02): officer or director change
Marianne De Backer adds the President title to her CEO role at Vir Biotechnology in San Francisco, a leadership change with no stated impact on hiring or roles.
- 2025-12-31Pay Change Pay and benefits
Vir Biotechnology, Inc.: $7,834,045 total compensation for the principal executive officer, fiscal year ended 2025-12-31
Top-of-house pay is the anchor the rest of an employer's pay structure is set against, and it is the one compensation figure every US-listed company must publish on the same basis. Read it as a comparable, not as a salary band: it is a single officer's total, including equity awards valued under SEC rules, and it says nothing directly about what a given role pays.
Vir Biotechnology. Talent Intelligence Tracker, AskTheRecruiter.com. Accessed Aug 20, 2026. https://asktherecruiter.com/blog/talent-intelligence-tracker/company/vir-biotechnology/ Licensed CC BY 4.0; every record links to the document behind it.The read-through on each line is our interpretation. The headline and figures come from the linked source. Data licensed CC BY 4.0. Back to the tracker